Showing results (411-420 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|December 7, 2017
NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndromeJie Liu, Zan Wan, Qianqian Song, et al.
Pharmacogenomics|December 15, 2017
Pharmacogenetic landscape of DPYD variants in south Asian populations by integration of genome-scale dataJudith M Hariprakash, Shamsudheen K Vellarikkal, Pavithran Keechilat, et al.
Pharmacogenomics|September 28, 2017
Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipientsBo Sun, Yankun Guo, Junwei Gao, et al.
Pharmacogenomics|July 7, 2016
Influx transporter variants as predictors of cancer chemotherapy-induced toxicity: systematic review and meta-analysisZoulikha M Zaïr, Donald Rj Singer
Pharmacogenomics|August 24, 2017
miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinomaJisce R Puik, Laura L Meijer, Tessa Ys Le Large, et al.
Pharmacogenomics|August 24, 2017
The Pharmacogenetics Laboratory of the Department of Pharmacology and Toxicology at the American University of Beirut Faculty of MedicineNathalie K Zgheib
Pharmacogenomics|July 6, 2016
Pharmacogenomic and personalized approaches to tackle nonalcoholic fatty liver diseaseGregor Lorbek, Žiga Urlep, Damjana Rozman
Pharmacogenomics|February 20, 2018
Novel approach for CES1 genotyping: integrating single nucleotide variants and structural variationDitte Bjerre, Henrik Berg Rasmussen, The Indices Consortium
Pharmacogenomics|January 16, 2018
Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in EuropeJennifer G Gaultney, Therese W Ng, Carin A Uyl-de Groot, et al.
Pharmacogenomics|January 11, 2018
Effect of genetic polymorphisms in SREBF-SCAP pathway on therapeutic response to rosuvastatin in Saudi metabolic syndrome patientsMisbahuddin Mohd Rafeeq, Hamed Said Habib, Hussam Aly Sayed Murad, et al.
Pageof 276